Search research articles
Contact Us
Filters
Showing results (21-30 of 199) with videos related to
Page
of 20
Sort By:
Ebiomedicine
|
July 14, 2016
Oncolytic Viruses: Therapeutics With an Identity Crisis
Caroline J Breitbach, Brian D Lichty, John C Bell
Trends in Cancer
|
July 26, 2017
Oncolytic Viruses: Exploiting Cancer's Deal with the Devil
Larissa A Pikor, John C Bell, Jean-Simon Diallo
Stem Cells (Dayton, Ohio)
|
March 16, 2019
Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses
Mathieu J F Crupi, John C Bell, Ragunath Singaravelu
Nature Biotechnology
|
July 12, 2012
Oncolytic virotherapy
Stephen J Russell, Kah-Whye Peng, John C Bell
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 21, 2011
Thunder and lightning: immunotherapy and oncolytic viruses collide
Alan Melcher, Kelley Parato, Cliona M Rooney, et al.
Immunobiology
|
December 19, 2007
Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells
Zoe Waibler, Claudia N Detje, John C Bell, et al.
The Journal of General Virology
|
October 13, 2006
Matrix protein of Vesicular stomatitis virus harbours a cryptic mitochondrial-targeting motif
Brian D Lichty, Heidi McBride, Stephen Hanson, et al.
Molecular Therapy Oncolytics
|
June 14, 2019
An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate <i>In Vivo</i>
Josh Del Papa, Julia Petryk, John C Bell, et al.
Cytokine & Growth Factor Reviews
|
March 12, 2010
Novel oncolytic viruses: riding high on the next wave?
Marianne M Stanford, John C Bell, Markus J V Vähä-Koskela
Communications Medicine
|
May 23, 2022
Advances in oncolytic virotherapy
Stephen J Russell, John C Bell, Christine E Engeland, et al.
Page
of 20
Search research articles
Search
Showing results (21-30 of 199) with videos related to
Sort By:
Page
of 20
Ebiomedicine
|
July 14, 2016
Oncolytic Viruses: Therapeutics With an Identity Crisis
Caroline J Breitbach, Brian D Lichty, John C Bell
Trends in Cancer
|
July 26, 2017
Oncolytic Viruses: Exploiting Cancer's Deal with the Devil
Larissa A Pikor, John C Bell, Jean-Simon Diallo
Stem Cells (Dayton, Ohio)
|
March 16, 2019
Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses
Mathieu J F Crupi, John C Bell, Ragunath Singaravelu
Nature Biotechnology
|
July 12, 2012
Oncolytic virotherapy
Stephen J Russell, Kah-Whye Peng, John C Bell
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 21, 2011
Thunder and lightning: immunotherapy and oncolytic viruses collide
Alan Melcher, Kelley Parato, Cliona M Rooney, et al.
Immunobiology
|
December 19, 2007
Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells
Zoe Waibler, Claudia N Detje, John C Bell, et al.
The Journal of General Virology
|
October 13, 2006
Matrix protein of Vesicular stomatitis virus harbours a cryptic mitochondrial-targeting motif
Brian D Lichty, Heidi McBride, Stephen Hanson, et al.
Molecular Therapy Oncolytics
|
June 14, 2019
An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate <i>In Vivo</i>
Josh Del Papa, Julia Petryk, John C Bell, et al.
Cytokine & Growth Factor Reviews
|
March 12, 2010
Novel oncolytic viruses: riding high on the next wave?
Marianne M Stanford, John C Bell, Markus J V Vähä-Koskela
Communications Medicine
|
May 23, 2022
Advances in oncolytic virotherapy
Stephen J Russell, John C Bell, Christine E Engeland, et al.
Page
of 20